Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/74—Synthetic polymeric materials
  • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents

Definitions

• the present invention relates to a remedy for internal use, especially against cancer.
• This object is achieved by a remedy which has polydimethylsiloxane and surfactants, the proportion of polydimethylsiloxane exceeding the proportion of surfactants.
• the special feature of the invention is that the effect according to the invention is achieved only by adding surfactants.
• Mixing the polydimethylsiloxane with surfactants means that the body is given the opportunity to emulsify the siloxane and make it usable. This is achieved by the surfactants breaking up the molecular structure of the polydimethylsiloxane.
• the proportion of surfactants, based on the weight of the solution, can be significantly lower than the proportion of polydimethylsiloxane.
• Anionic, amphoteric and nonionic surfactants can be used, the proportion by weight of the anionic surfactants exceeding the proportion by weight of the amphoteric and nonionic.
• Polydimethylsiloxane is made from raw silicon.
• Raw silicon is obtained from sand and coal, which is further processed into the desired silicones in a continuous process.
• Natural gas or crude oil are used to produce methanol (synthesis gas), another starting material for silicone synthesis.
• Chlorine is obtained by electrolysis of rock salt solutions and is added to the process in the form of HC1.
• methanol is converted to chloromethane with HC1 (chloromethane synthesis).
• a mixture of crude silanes (chlorosilane synthesis) is then obtained by reacting chloromethane with silicon. These are separated by distillation, dichlorodimethylsilane (CH3) 2SiC12 then being converted into polydimethylsiloxane by hydrolysis.
• the remedy is nebulized using suitable nebulization techniques.
• suitable nebulization techniques Various devices are available for this:
• Compressed air operated Venturi nozzle nebulizer a) direct nebulization b) with aerosol reservoir c) with positive pressure inhalation 2.
• Mechanical single-component jet nebulizer a) direct nebulization b) with aerosol reservoir c) with positive pressure inhalation 2.
• aluminum silicate in particular natural zeolite with a grain size of 10 ⁇ m to 70 ⁇ m, in particular 40 ⁇ m and dolomite powder with a grain size of 2 ⁇ m to 30 ⁇ m, in particular 10 ⁇ m, can also be added. This results in powder that can be administered in capsules.
• the basic skeleton of the crystal lattice of the zeolite consists primarily of SiÜ4 tetrahedra. It has cavities in which ions, e.g. B. are sodium, potassium and calcium, which can be easily exchanged with themselves and with their substrate environment.
• This mineral-specific crystal structure (cage structure) of zeolite has the excellent property in living organisms, toxic substances, such as. B. ammonia and other nitrogen compounds, but also heavy metals, to bind (absorb) and excrete via the intestinal metabolism. The extracted toxic substances are exchanged for minerals that the body urgently needs. In this way, the homeostasis of the organism, in particular that of the mineral metabolism, is maintained or restored.
• the zeolite also has a positive stimulating effect on the entire metabolism and in the growth and healing processes of the organism.
• zeolite Because of its open molecular structure, zeolite also has the ability to absorb large quantities of liquids. This is advantageous since, despite mixing with the additional components mentioned above, a flowable powder can be formed.
• the additional components may have the proportions in the end product:
• Aluminum silicate 50 to 90, in particular 70% by weight,
• the resulting mixture is a flowable powder and can be processed into a remedy in a variety of ways. It is thus possible to encapsulate the powdery mixture, for example in the form of the widely used gelatin capsules, which dissolve in the digestive tract. In addition, it is readily possible to press tablets from the powdered mixture, which can be taken with or without liquid.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Chemical & Material Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Epidemiology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Preparation (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Priority Applications (5)

Applications Claiming Priority (2)

Publications (1)

Family

ID=33441299

Family Applications (1)

Country Status (9)

Families Citing this family (11)

Citations (3)

Family Cites Families (3)

• 2003
  • 2003-05-22 DE DE10323758A patent/DE10323758A1/de not_active Withdrawn
• 2004
  • 2004-05-19 EP EP04733761A patent/EP1635849A1/de not_active Withdrawn
  • 2004-05-19 RU RU2005140097/15A patent/RU2005140097A/ru unknown
  • 2004-05-19 JP JP2006529603A patent/JP2006528211A/ja not_active Withdrawn
  • 2004-05-19 WO PCT/DE2004/001048 patent/WO2004105776A1/de not_active Ceased
  • 2004-05-19 US US10/557,317 patent/US20070172435A1/en not_active Abandoned
  • 2004-05-19 CA CA002526175A patent/CA2526175A1/en not_active Abandoned
  • 2004-05-19 CN CNA2004800140406A patent/CN1795001A/zh active Pending
  • 2004-05-19 AU AU2004243524A patent/AU2004243524A1/en not_active Abandoned

Patent Citations (3)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events